Biotech Coverage Statistics
Original analysis of our own accumulated coverage — not a syndicated report. Every figure below is a live, real-time aggregate computed directly from our source-verified story record. See our editorial methodology for how stories are classified, scored, and verified.
Coverage by Category
Story count per category, all-time. Download full dataset (CSV).
Volume vs. Impact: Where the Headlines Aren't the Story
Our most-covered category isn't our most consequential one: Pharma generates the most stories (465), but Acquisitions carries the highest average impact score (6.9/10) despite far fewer stories (18). Coverage volume and consequence are different signals.
Sentiment Distribution
Directional read of 702 classified stories — the development's implication for the space, not the tone of the reporting.
Most-Mentioned Entities
Ranked by distinct story mentions, all-time — the companies, people, and technologies our coverage returns to most often.
- 1 FDA organization 70
- 2 Novo Nordisk company 34
- 3 Eli Lilly company 32
- 4 Pfizer company 18
- 5 GSK company 16
- 6 FDA company 13
- 7 China country 11
- 8 Donald Trump person 11
- 9 Moderna company 11
- 10 Novartis company 10
- 11 Artificial Intelligence technology 10
- 12 Robert F. Kennedy Jr. person 10
- 13 CDC organization 9
- 14 AstraZeneca company 9
- 15 Johnson & Johnson company 9
How This Page Is Computed
Every figure on this page is a live SQL aggregate over our own accumulated story and entity records — never a manual estimate or a syndicated third-party statistic. Category and sentiment figures cover all stories ever tracked in this niche; the entity ranking counts distinct story mentions above our minimum relevance threshold (see methodology). Found a discrepancy? Email hello@getbiobrief.com.
Cite This Page
"Biotech Coverage Statistics: 702 Stories Analyzed." Biotech Intelligence Brief. https://getbiobrief.com/statistics